Tag: AcelRx Pharmaceuticals

All

Clinical Data on the Use of Sufentanil Sublingual Tablet During Awake Plastic Surgery Procedures is Published

Awake plastic surgery procedures can be performed using sublingual sufentanil tablet (30 mcg) with minimal side effects and a rapid recovery time, according to new research.

Trial Shows Dsuvia Reduces Need for Opioids in Recovery
AcelRx Pharmaceuticals Releases Trial Results on Sufentanil Sublingual Tablet
AcelRx Pharmaceuticals Presents Large Cohort of Complex Plastic Surgery Procedures Performed with DSUVIA

All

Sorry, No Posts Found

All

AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Vitiligo

If approved, upadacitinib will be the first systemic medication available for patients with vitiligo, according to the company.

FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA
HHS Leaders Back Plastic Surgeons’ Opposition to Gender-Related Surgery for Minors
Recent Antibiotic Use Raises Infection Risk in Tissue Expander–Based Breast Reconstruction

Tag: AcelRx Pharmaceuticals

All

Clinical Data on the Use of Sufentanil Sublingual Tablet During Awake Plastic Surgery Procedures is Published

Trial Shows Dsuvia Reduces Need for Opioids in Recovery

AcelRx Pharmaceuticals Releases Trial Results on Sufentanil Sublingual Tablet

AcelRx Pharmaceuticals Presents Large Cohort of Complex Plastic Surgery Procedures Performed with DSUVIA

All

Sorry, No Posts Found

All

AbbVie Submits Regulatory Applications to FDA and EMA for Upadacitinib in Vitiligo

FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA

HHS Leaders Back Plastic Surgeons’ Opposition to Gender-Related Surgery for Minors

Recent Antibiotic Use Raises Infection Risk in Tissue Expander–Based Breast Reconstruction

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links